Načítá se...
Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain-barrier and impairs iron-dependent hippocampal neuron dendrite development
BACKGROUND: Thrombocytopenia is common in sick neonates. Thrombopoietin mimetics (e.g., eltrombopag (ELT)) might provide an alternative therapy for selected neonates with severe and prolonged thrombocytopenia, and for infants and young children with different varieties of thrombocytopenia. However,...
Uloženo v:
Vydáno v: | J Thromb Haemost |
---|---|
Hlavní autoři: | , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5334144/ https://ncbi.nlm.nih.gov/pubmed/28005311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13602 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|